Logo-aim
Arch Iran Med. 2024;27(11): 629-632.
doi: 10.34172/aim.31792
PMID: 39534998
PMCID: PMC11558610
Scopus ID: 85209128832
  Abstract View: 1605
  PDF Download: 1043
  Full Text View: 643

Opinion

Toll-Like Receptors Agonists: First-Line Defense Tools in the Pandemic Preparedness Arsenal?

Farrokh Habibzadeh 1* ORCID logo, Parham Habibzadeh 2, Mihai G. Netea 3,4, Mahboobeh Yadollahie 5

1 Independent Research Consultant, Shiraz, Iran
2 Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA
3 Radboud Center for Infectious Diseases, Department of Internal Medicine, Radboud University Medical Center, Nijmegen, Netherlands
4 Department of Immunology and Metabolism, Life and Medical Science Institute, University of Bonn, Bonn, Germany
5 Independent Researcher, Shiraz, Iran
*Corresponding Author: Farrokh Habibzadeh, Email: Farrokh.Habibzadeh@gmail.com
Cite this article as: Habibzadeh F, Habibzadeh P, Netea MG, Yadollahie M. Toll-like receptors agonists: first-line defense tools in the pandemic preparedness arsenal? Arch Iran Med. 2024;27(11):629-632. doi: 10.34172/aim.31792
First Name
Last Name
Email Address
Comments
Security code


Abstract View:

Your browser does not support the canvas element.

PDF Download:

Your browser does not support the canvas element.

Full Text View:

Your browser does not support the canvas element.